RxDoctor Payments Data

Chad Campbell, PA

Physician Assistant · Globe, AZNPI 1982763470

Payments from drug & device makers

$543in general payments, 2019–2025

Across 30 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$85
  • Boehringer Ingelheim$72
  • Abbott$63
  • AbbVie$52
  • Takeda Pharmaceuticals U.S.A., Inc.$50
  • Medtronic$31
  • plus $191 from 11 others

What the payments were for

  • Food & beverage$52597%
  • Entertainment$183%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$543 in reported general payments places this provider in the 60th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$42,029
Medicare patients
73
Services billed
1,005

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin62$67,873
ZenpepLipase/Protease/Amylase19$55,875
OzempicSemaglutide30$49,946
Tresiba Flextouch U-200Insulin Degludec12$20,538
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$12,740
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$6,121
LantusInsulin Glargine,hum.Rec.Anlog13$3,376
BreynaBudesonide/Formoterol Fumarate12$2,805
Testosterone16$1,788
Tamsulosin Hcl43$1,073
Levothyroxine Sodium88$731
Atorvastatin Calcium81$690
Valsartan21$655
Klor-Con M20Potassium Chloride12$620
Pravastatin Sodium29$520

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$72$67,87362 claims
Aimmune Therapeutics, Inc.Zenpep$15$55,87519 claims
Novo NordiskOzempic$85$49,94630 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Globe

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →